Scarica l'app Stockscreener
7.78
3.80%
0.285
Dopo l'orario di chiusura:
7.78
Precedente Chiudi:
$7.495
Aprire:
$7.56
Volume 24 ore:
46,506
Relative Volume:
0.15
Capitalizzazione di mercato:
$253.84M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-3.71%
1M Prestazione:
+6.72%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$7.32
$7.8709
Intervallo di 1 settimana:
$7.32
$8.12
Portata 52W:
$6.565
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Nome
Jade Biosciences Inc
Settore
Industria
Telefono
617-443-2400
Indirizzo
930 WINTER STREET, WALTHAM
Confronta JBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
7.78 | 248.62M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | Jefferies | Buy |
| 2025-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-05-07 | Iniziato | Wedbush | Outperform |
| 2025-05-05 | Iniziato | Stifel | Buy |
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2024-06-18 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Downgrade | TD Cowen | Buy → Hold |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-06-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-03-25 | Ripresa | Jefferies | Buy |
| 2023-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Jade Biosciences Inc Borsa (JBIO) Ultime notizie
Risk On: How volatile is Jade Biosciences Inc. stockJuly 2025 Macro Moves & Community Consensus Trade Alerts - khodrobank.com
Predicting Jade Biosciences Inc. trend using moving averagesJuly 2025 Sentiment & High Accuracy Buy Signal Tips - Newser
Leading vs lagging indicators on Jade Biosciences Inc. performance2025 Dividend Review & Reliable Breakout Stock Forecasts - Newser
Using R and stats models for Jade Biosciences Inc. forecastingMarket Growth Review & Fast Exit and Entry Trade Guides - Newser
Custom strategy builders for tracking Jade Biosciences Inc.Long Setup & Accurate Entry/Exit Alerts - Newser
Is Jade Biosciences Inc. forming a bullish divergencePortfolio Risk Report & Fast Gain Stock Tips - khodrobank.com
Regression analysis insights on Jade Biosciences Inc. performanceGap Down & Comprehensive Market Scan Insights - Newser
Sentiment analysis tools applied to Jade Biosciences Inc.July 2025 Patterns & AI Powered Market Entry Strategies - Newser
Is Jade Biosciences Inc. still worth holding after the dipTrade Signal Summary & Fast Exit and Entry Trade Guides - Newser
Jade Biosciences Inc. stock outlook for YEARWeekly Trend Report & Daily Chart Pattern Signals - Newser
Will Jade Biosciences Inc. bounce back from current support2025 Price Targets & Precise Trade Entry Recommendations - Newser
Published on: 2025-09-03 01:07:06 - Newser
How to interpret RSI for Jade Biosciences Inc. stockQuarterly Profit Review & Short-Term High Return Ideas - Newser
Can Jade Biosciences Inc. expand its profit marginsPortfolio Gains Summary & AI Based Trade Execution Alerts - khodrobank.com
Key resistance and support levels for Jade Biosciences Inc.2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
What to do if you’re stuck in Jade Biosciences Inc.July 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser
How sentiment analysis helps forecast Jade Biosciences Inc.Quarterly Market Summary & AI Enhanced Execution Alerts - Newser
Can Jade Biosciences Inc. outperform under higher oil prices2025 Market Sentiment & Target Return Focused Stock Picks - khodrobank.com
How is Jade Biosciences Inc. managing supply chain issues2025 Winners & Losers & Community Verified Trade Alerts - khodrobank.com
What makes Jade Biosciences Inc. stock price move sharplyMarket Sentiment Review & Entry Point Confirmation Signals - Newser
Jade Biosciences announces first cohort dosed in phase 1 healthy volunteer clinical trial of Jade101, a novel and potentially best-in-class anti-April monoclonal antibody being evaluated for the treatment of IgA nephropathy - MarketScreener
Will Jade Biosciences Inc. benefit from current market trendsPortfolio Return Report & Real-Time Buy Signal Notifications - khodrobank.com
Is Jade Biosciences Inc.’s growth already priced in2025 Market Outlook & Verified High Yield Trade Plans - khodrobank.com
Jade Biosciences Announces First Cohort Dosed in Phase 1 - GlobeNewswire
Breakthrough IgA Nephropathy Treatment: Jade Bio's JADE101 Begins Human Trials with 8-Week Dosing Potential - Stock Titan
Can Jade Biosciences Inc. expand into new marketsWeekly Trade Review & Daily Technical Stock Forecast Reports - khodrobank.com
Jade Biosciences Inc. stock momentum explainedBuy Signal & Fast Exit/Entry Strategy Plans - Newser
Is Jade Biosciences Inc. subject to activist investor interestCEO Change & AI Driven Stock Price Forecasts - khodrobank.com
How Jade Biosciences Inc. stock performs during market volatilityWeekly Profit Summary & Low Risk High Win Rate Picks - Newser
Automated trading signals detected on Jade Biosciences Inc.Fed Meeting & Safe Capital Investment Plans - Newser
Published on: 2025-09-01 22:47:14 - Newser
Can Jade Biosciences Inc. outperform in the next rallyJuly 2025 Trends & Smart Money Movement Alerts - khodrobank.com
Does Jade Biosciences Inc. align with a passive investing strategy2025 Big Picture & Technical Pattern Based Buy Signals - خودرو بانک
Does Jade Biosciences Inc. stock benefit from AI growth2025 Historical Comparison & Fast Exit/Entry Strategy Plans - khodrobank.com
Aug Levels: Will Jade Biosciences Inc. benefit from government policyQuarterly Portfolio Report & Weekly Breakout Watchlists - khodrobank.com
What are Jade Biosciences Inc.’s technical support levels2025 Price Action Summary & Weekly Sector Rotation Insights - khodrobank.com
Jade Biosciences Inc. Attempts Reversal From Key Support getLinesFromResByArray error: size == 0 - kangso.co.kr
What dividend growth rate does Jade Biosciences Inc. offer2025 Volatility Report & Weekly Watchlist for Consistent Profits - khodrobank.com
Volume spikes in Jade Biosciences Inc. stock – what they meanWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Using fundamentals and technicals on Jade Biosciences Inc.Take Profit & Reliable Price Action Trade Plans - Newser
Building trade automation scripts for Jade Biosciences Inc.Portfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Is Jade Biosciences Inc. likely to announce a buyback2025 Fundamental Recap & Weekly Breakout Watchlists - kpenews.com
Is Jade Biosciences Inc. Forming a Consolidation Base getLinesFromResByArray error: size == 0 - 더경남뉴스
Will Jade Biosciences Inc. price bounce be sustainableMarket Movement Recap & Reliable Breakout Forecasts - Newser
Sector ETF performance correlation with Jade Biosciences Inc.Market Trend Summary & High Accuracy Investment Signals - Newser
Jade Biosciences Inc Azioni (JBIO) Dati Finanziari
Non sono disponibili dati finanziari per Jade Biosciences Inc (JBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):